| 标题 |
Safety, Tolerability, and Efficacy of Mezagitamab (TAK-079) as Add-On to Standard of Care Therapy in Individuals with Primary IgA Nephropathy: Interim Results from an Open-Label Phase 1b Study |
| 网址 | |
| DOI |
10.1681/asn.20243d4074tq
doi
|
| 其它 |
期刊:Journal of the American Society of Nephrology 作者:Jonathan Barratt; Yusuke Suzuki; Van Anh Nguyen; Iwona Dobler; Cheryl Li; et al 出版日期:2024-10-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)